It’s easy to see NP was buying more time with this PR (50days) knowing the FDA wants to see more patients enrolled to supplement critical data. This gave them more time to enroll open label patients. We are now looking at subgroup (Critical) of the trial being the FDA focus for LL. Why state in the PR about 45 open label patients have been enrolled since the official end of the trial? It’s like he is preparing us for the number of patients needed to fill the trial extension to be announced Monday.

If this is so positive, why Friday at 6:00 PM? Why not Monday morning? The underlying message is that there isn’t enough data for EUA. I want to be wrong, but I think most of us who have been around a while can read between the lines. I have always been real with my opinions.
I’m not selling a share.......going to be a long weekend. I would like for all of you to explain why I am wrong. I want to feel different going into this weekend. As always GLTA!! No more posts available. Good night.